211 related articles for article (PubMed ID: 20060267)
1. CD147/basigin promotes progression of malignant melanoma and other cancers.
Kanekura T; Chen X
J Dermatol Sci; 2010 Mar; 57(3):149-54. PubMed ID: 20060267
[TBL] [Abstract][Full Text] [Related]
2. A CD147-targeting siRNA inhibits the proliferation, invasiveness, and VEGF production of human malignant melanoma cells by down-regulating glycolysis.
Su J; Chen X; Kanekura T
Cancer Lett; 2009 Jan; 273(1):140-7. PubMed ID: 18778892
[TBL] [Abstract][Full Text] [Related]
3. A small interfering CD147-targeting RNA inhibited the proliferation, invasiveness, and metastatic activity of malignant melanoma.
Chen X; Lin J; Kanekura T; Su J; Lin W; Xie H; Wu Y; Li J; Chen M; Chang J
Cancer Res; 2006 Dec; 66(23):11323-30. PubMed ID: 17145878
[TBL] [Abstract][Full Text] [Related]
4. CD147-targeting siRNA inhibits cell-matrix adhesion of human malignant melanoma cells by phosphorylating focal adhesion kinase.
Nishibaba R; Higashi Y; Su J; Furukawa T; Kawai K; Kanekura T
J Dermatol; 2012 Jan; 39(1):63-7. PubMed ID: 21967109
[TBL] [Abstract][Full Text] [Related]
5. CD147 silencing inhibits lactate transport and reduces malignant potential of pancreatic cancer cells in in vivo and in vitro models.
Schneiderhan W; Scheler M; Holzmann KH; Marx M; Gschwend JE; Bucholz M; Gress TM; Seufferlein T; Adler G; Oswald F
Gut; 2009 Oct; 58(10):1391-8. PubMed ID: 19505879
[TBL] [Abstract][Full Text] [Related]
6. Blocking CD147 induces cell death in cancer cells through impairment of glycolytic energy metabolism.
Baba M; Inoue M; Itoh K; Nishizawa Y
Biochem Biophys Res Commun; 2008 Sep; 374(1):111-6. PubMed ID: 18616931
[TBL] [Abstract][Full Text] [Related]
7. HAb18G/CD147 functions in invasion and metastasis of hepatocellular carcinoma.
Xu J; Xu HY; Zhang Q; Song F; Jiang JL; Yang XM; Mi L; Wen N; Tian R; Wang L; Yao H; Feng Q; Zhang Y; Xing JL; Zhu P; Chen ZN
Mol Cancer Res; 2007 Jun; 5(6):605-14. PubMed ID: 17579119
[TBL] [Abstract][Full Text] [Related]
8. Emmprin (basigin/CD147): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression.
Nabeshima K; Iwasaki H; Koga K; Hojo H; Suzumiya J; Kikuchi M
Pathol Int; 2006 Jul; 56(7):359-67. PubMed ID: 16792544
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of CD147 gene expression via RNA interference reduces tumor cell invasion, tumorigenicity and increases chemosensitivity to cisplatin in laryngeal carcinoma Hep2 cells.
Zhu C; Pan Y; He B; Wang B; Xu Y; Qu L; Bao Q; Tian F; Wang S
Oncol Rep; 2011 Feb; 25(2):425-32. PubMed ID: 21165561
[TBL] [Abstract][Full Text] [Related]
10. Repressing CD147 is a novel therapeutic strategy for malignant melanoma.
Hu X; Su J; Zhou Y; Xie X; Peng C; Yuan Z; Chen X
Oncotarget; 2017 Apr; 8(15):25806-25813. PubMed ID: 28445958
[TBL] [Abstract][Full Text] [Related]
11. CD147 impacts angiogenesis and metastasis formation.
Voigt H; Vetter-Kauczok CS; Schrama D; Hofmann UB; Becker JC; Houben R
Cancer Invest; 2009 Mar; 27(3):329-33. PubMed ID: 19160100
[TBL] [Abstract][Full Text] [Related]
12. RNA interference targeting CD147 inhibits the proliferation, invasiveness, and metastatic activity of thyroid carcinoma cells by down-regulating glycolysis.
Huang P; Chang S; Jiang X; Su J; Dong C; Liu X; Yuan Z; Zhang Z; Liao H
Int J Clin Exp Pathol; 2015; 8(1):309-18. PubMed ID: 25755717
[TBL] [Abstract][Full Text] [Related]
13. CD147 regulates vascular endothelial growth factor-A expression, tumorigenicity, and chemosensitivity to curcumin in hepatocellular carcinoma.
Jia L; Wang H; Qu S; Miao X; Zhang J
IUBMB Life; 2008 Jan; 60(1):57-63. PubMed ID: 18379992
[TBL] [Abstract][Full Text] [Related]
14. Silencing CD147 inhibits tumor progression and increases chemosensitivity in murine lymphoid neoplasm P388D1 cells.
Jia L; Wei W; Cao J; Xu H; Miao X; Zhang J
Ann Hematol; 2009 Aug; 88(8):753-60. PubMed ID: 19125248
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of CD147 gene expression via RNA interference reduces tumor cell invasion, tumorigenicity and increases chemosensitivity to paclitaxel in HO-8910pm cells.
Zou W; Yang H; Hou X; Zhang W; Chen B; Xin X
Cancer Lett; 2007 Apr; 248(2):211-8. PubMed ID: 16930823
[TBL] [Abstract][Full Text] [Related]
16. The roles of CD147 in the progression of gliomas.
Fei F; Li S; Fei Z; Chen Z
Expert Rev Anticancer Ther; 2015; 15(11):1351-9. PubMed ID: 26414447
[TBL] [Abstract][Full Text] [Related]
17. RNA interference targeting the CD147 induces apoptosis of multi-drug resistant cancer cells related to XIAP depletion.
Kuang YH; Chen X; Su J; Wu LS; Liao LQ; Li D; Chen ZS; Kanekura T
Cancer Lett; 2009 Apr; 276(2):189-95. PubMed ID: 19097686
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of CD147 in ovarian cancer is initiated by the hypoxic microenvironment.
Yang H; Zou W; Chen B
Cell Biol Int; 2013 Oct; 37(10):1139-42. PubMed ID: 23686717
[TBL] [Abstract][Full Text] [Related]
19. A novel interaction between calcium-modulating cyclophilin ligand and Basigin regulates calcium signaling and matrix metalloproteinase activities in human melanoma cells.
Long T; Su J; Tang W; Luo Z; Liu S; Liu Z; Zhou H; Qi M; Zeng W; Zhang J; Chen X
Cancer Lett; 2013 Oct; 339(1):93-101. PubMed ID: 23879967
[TBL] [Abstract][Full Text] [Related]
20. Let-7b-mediated suppression of basigin expression and metastasis in mouse melanoma cells.
Fu TY; Chang CC; Lin CT; Lai CH; Peng SY; Ko YJ; Tang PC
Exp Cell Res; 2011 Feb; 317(4):445-51. PubMed ID: 21087605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
